Literature DB >> 21716264

Smoke extracts and nicotine, but not tobacco extracts, potentiate firing and burst activity of ventral tegmental area dopaminergic neurons in mice.

Fabio Marti1, Ouafa Arib, Carole Morel, Virginie Dufresne, Uwe Maskos, Pierre-Jean Corringer, Renaud de Beaurepaire, Philippe Faure.   

Abstract

Nicotine prominently mediates the behavioral effects of tobacco consumption, either through smoking or when taking tobacco by snuff or chew. However, many studies question the exclusive role of nicotine in these effects. The use of preparations containing all the components of tobacco, such as tobacco and smoke extracts, may be more suitable than nicotine alone to investigate the behavioral effects of smoking and tobacco intake. In the present study, the electrophysiological effects of tobacco and smoke on ventral tegmental area dopaminergic (DA) neurons were examined in vivo in anesthetized wild-type (WT), β2-nicotinic acetylcholine receptor (nAChR) knockout (β2-/-), α4-/-, and α6-/- mice and compared with those of nicotine alone. In WT mice, smoke and nicotine had similar potentiating effects on DA cell activity, but the action of tobacco on neuronal firing was weak and often inhibitory. In particular, nicotine triggered strong bursting activity, whereas no bursting activity was observed after tobacco extract (ToE) administration. In β2-/- mice, nicotine or extract elicited no modification of the firing patterns of DA cells, indicating that extract acts predominantly through nAChRs. The differences between DA cell activation profiles induced by tobacco and nicotine alone observed in WT persisted in α6-/- mice but not in α4-/- mice. These results would suggest that tobacco has lower addiction-generating properties compared with either nicotine alone or smoke. The weak activation and prominent inhibition obtained with ToEs suggest that tobacco contains compounds that counteract some of the activating effects of nicotine and promote inhibition on DA cell acting through α4β2*-nAChRs. The nature of these compounds remains to be elucidated. It nevertheless confirms that nicotine is the main substance involved in the tobacco addiction-related activation of mesolimbic DA neurons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21716264      PMCID: PMC3176561          DOI: 10.1038/npp.2011.112

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  49 in total

1.  A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use.

Authors:  G Di Chiara
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

2.  Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine.

Authors:  M R Picciotto; M Zoli; R Rimondini; C Léna; L M Marubio; E M Pich; K Fuxe; J P Changeux
Journal:  Nature       Date:  1998-01-08       Impact factor: 49.962

3.  Harman-induced changes of extracellular concentrations of neurotransmitters in the nucleus accumbens of rats.

Authors:  S S Baum; R Hill; H Rommelspacher
Journal:  Eur J Pharmacol       Date:  1996-10-24       Impact factor: 4.432

4.  Smokeless tobacco, oxidative stress, apoptosis, and antioxidants in human oral keratinocytes.

Authors:  M Bagchi; J Balmoori; D Bagchi; S D Ray; C Kuszynski; S J Stohs
Journal:  Free Radic Biol Med       Date:  1999-04       Impact factor: 7.376

5.  Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler.

Authors:  P Hajek; R West; J Foulds; F Nilsson; S Burrows; A Meadow
Journal:  Arch Intern Med       Date:  1999-09-27

6.  Nicotine and food induced dopamine release in the nucleus accumbens of the rat: putative role of alpha7 nicotinic receptors in the ventral tegmental area.

Authors:  B Schilström; H M Svensson; T H Svensson; G G Nomikos
Journal:  Neuroscience       Date:  1998-08       Impact factor: 3.590

7.  Subchronic effects of smokeless tobacco extract (STE) on hepatic lipid peroxidation, DNA damage and excretion of urinary metabolites in rats.

Authors:  M Bagchi; D Bagchi; E A Hassoun; S J Stohs
Journal:  Toxicology       Date:  1998-05-15       Impact factor: 4.221

8.  Electrophysiological characterization of GABAergic neurons in the ventral tegmental area.

Authors:  S C Steffensen; A L Svingos; V M Pickel; S J Henriksen
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

9.  Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors.

Authors:  D S McGehee; M J Heath; S Gelber; P Devay; L W Role
Journal:  Science       Date:  1995-09-22       Impact factor: 47.728

10.  Minor alkaloids of tobacco release [3H]dopamine from superfused rat striatal slices.

Authors:  L P Dwoskin; L Teng; S T Buxton; A Ravard; N Deo; P A Crooks
Journal:  Eur J Pharmacol       Date:  1995-03-24       Impact factor: 4.432

View more
  15 in total

1.  Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal.

Authors:  John A Dani; Mariella De Biasi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

2.  Neurophysiology of Nicotine Addiction.

Authors:  John A Dani; Daniel Jenson; John I Broussard; Mariella De Biasi
Journal:  J Addict Res Ther       Date:  2011-04-20

3.  Denicotinized versus average nicotine tobacco cigarette smoking differentially releases striatal dopamine.

Authors:  Edward F Domino; Lisong Ni; Joseph S Domino; Wendy Yang; Catherine Evans; Sally Guthrie; Heng Wang; Robert A Koeppe; Jon-Kar Zubieta
Journal:  Nicotine Tob Res       Date:  2012-04-05       Impact factor: 4.244

4.  Genetic deletion or pharmacological blockade of nociceptin/orphanin FQ receptors in the ventral tegmental area attenuates nicotine-motivated behaviour.

Authors:  Ana Domi; Veronica Lunerti; Michele Petrella; Esi Domi; Anna Maria Borruto; Massimo Ubaldi; Friedbert Weiss; Roberto Ciccocioppo
Journal:  Br J Pharmacol       Date:  2022-02-10       Impact factor: 9.473

5.  Nicotine consumption is regulated by a human polymorphism in dopamine neurons.

Authors:  C Morel; L Fattore; S Pons; Y A Hay; F Marti; B Lambolez; M De Biasi; M Lathrop; W Fratta; U Maskos; P Faure
Journal:  Mol Psychiatry       Date:  2013-12-03       Impact factor: 15.992

6.  Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats.

Authors:  Matthew R Costello; Daisy D Reynaga; Celina Y Mojica; Nurulain T Zaveri; James D Belluzzi; Frances M Leslie
Journal:  Neuropsychopharmacology       Date:  2014-02-11       Impact factor: 7.853

7.  Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.

Authors:  Deepak Cyril D'Souza; Daniel J Fridberg; Patrick D Skosnik; Ashley Williams; Brian Roach; Nagendra Singh; Michelle Carbuto; Jacqueline Elander; Ashley Schnakenberg; Brian Pittman; R Andrew Sewell; Mohini Ranganathan; Daniel Mathalon
Journal:  Neuropsychopharmacology       Date:  2012-02-15       Impact factor: 7.853

Review 8.  Nicotine and alcohol: the role of midbrain dopaminergic neurons in drug reinforcement.

Authors:  Carole Morel; Sarah Montgomery; Ming-Hu Han
Journal:  Eur J Neurosci       Date:  2018-10-15       Impact factor: 3.386

9.  Selective inhibition of phosphodiesterase 7 enzymes reduces motivation for nicotine use through modulation of mesolimbic dopaminergic transmission.

Authors:  Roberto Ciccocioppo; Giordano de Guglielmo; Hongwu Li; Miriam Melis; Lucia Caffino; Quienwei Shen; Ana Domi; Fabio Fumagalli; Gregory A Demopulos; George A Gaitanaris
Journal:  J Neurosci       Date:  2021-06-01       Impact factor: 6.167

Review 10.  Dopaminergic and cholinergic learning mechanisms in nicotine addiction.

Authors:  Manivannan Subramaniyan; John A Dani
Journal:  Ann N Y Acad Sci       Date:  2015-08-24       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.